Search - tctmd.com

Displaying 261 - 280 of 519

Sort: Relevancy | Date

News Daily News

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

Todd Neale

February 25, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Conference News ISC 2019

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

Todd Neale

February 11, 2019

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

Caitlin E. Cox

February 08, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

News Conference News ISET 2019

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

Caitlin E. Cox

January 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Conference News ISET 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Caitlin E. Cox

January 30, 2019

Presentation ISET 2019

Technical Tips and Tricks in Managing Chronic Mesenteric Ischemia

Presenter: John Angle

January 30, 2019

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

Carotid Artery Disease: Where Does Stenting Fit in 2019?

Presenter: Chris Metzger

January 30, 2019

News Conference News ISET 2019

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

Caitlin E. Cox

January 28, 2019

Presentation LINC 2019

How I Do It: Venous Stenting for Chronic Venous Obstruction (CVO)

Presenter: Angela A. Kokkosis

January 25, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

Advertisement

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Durability of Surgery, Stenting for Symptomatic Carotid Stenosis Good for Up to a Decade

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

TCTMD’s Top 10 Most Popular Stories for January 2019

Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis

Technical Tips and Tricks in Managing Chronic Mesenteric Ischemia

Drug-Coated Therapy for ISR: Review of Options and Data

Carotid Artery Disease: Where Does Stenting Fit in 2019?

Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched

How I Do It: Venous Stenting for Chronic Venous Obstruction (CVO)

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Top News in Endovascular Therapy: 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content